ArticleAnnals of translational medicine2019

Survivin is a prognostic marker and therapeutic target for extranodal, nasal-type natural killer/T cell lymphoma.

Li Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.